India · Delayed Price · Currency is INR Verve Therapeutics Statistics
Total Valuation
BOM:543396 has a market cap or net worth of INR 678.32 billion. The enterprise value is 548.15 billion.
| Market Cap | 678.32B |
| Enterprise Value | 548.15B |
Important Dates
The last earnings date was Friday, July 25, 2025.
| Earnings Date | Jul 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 638.48M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -2.62% |
| Shares Change (QoQ) | +1.70% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 400.36M |
Valuation Ratios
The trailing PE ratio is 224.09 and the forward PE ratio is 77.05.
| PE Ratio | 224.09 |
| Forward PE | 77.05 |
| PS Ratio | 9.27 |
| PB Ratio | 4.52 |
| P/TBV Ratio | 4.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 181.09 |
| EV / Sales | 7.49 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -78.93 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -5.58% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 1.86M |
| Profits Per Employee | 76,890 |
| Employee Count | 39,368 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:543396 has paid 205.00 million in taxes.
| Income Tax | 205.00M |
| Effective Tax Rate | 6.41% |
Stock Price Statistics
The stock price has increased by +109.53% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +109.53% |
| 50-Day Moving Average | 970.29 |
| 200-Day Moving Average | 868.23 |
| Relative Strength Index (RSI) | 59.91 |
| Average Volume (20 Days) | 2,482,883 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:543396 had revenue of INR 73.16 billion and earned 3.03 billion in profits. Earnings per share was 4.73.
| Revenue | 73.16B |
| Gross Profit | 21.50B |
| Operating Income | -12.79B |
| Pretax Income | 3.20B |
| Net Income | 3.03B |
| EBITDA | -6.06B |
| EBIT | -12.79B |
| Earnings Per Share (EPS) | 4.73 |
Balance Sheet
The company has 131.48 billion in cash and 1.60 billion in debt, giving a net cash position of 129.88 billion.
| Cash & Cash Equivalents | 131.48B |
| Total Debt | 1.60B |
| Net Cash | 129.88B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 149.97B |
| Book Value Per Share | 235.78 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 29.38%, with operating and profit margins of -17.48% and 4.14%.
| Gross Margin | 29.38% |
| Operating Margin | -17.48% |
| Pretax Margin | 4.37% |
| Profit Margin | 4.14% |
| EBITDA Margin | -8.28% |
| EBIT Margin | -17.48% |
| FCF Margin | n/a |
Dividends & Yields
BOM:543396 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.62% |
| Shareholder Yield | n/a |
| Earnings Yield | 0.45% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |